powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1023437290
Pamela Hayes
MD
Medical Oncology
Dallas,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
85.1
Quality
67.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.43%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$91
Payment records
4
By payment type
Food and Beverage
$76
Education
$16
Top paying entities
Food and Beverage
$76
Education
$16
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 450647
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
537
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
23
Brand share
39.7%
Top prescribed drugs
Anastrozole
97 claims
Dexamethasone
44 claims
Apixaban
42 claims
Rivaroxaban
40 claims
Hydrocodone/Acetaminophen
29 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,538
Unique beneficiaries
—
Total services
3,926
Distinct HCPCS
34
Medicare payment
$87K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 393 Medical Oncology providers in TX — above median (cohort median 4,999).
